PRE — Prenetics Global Ltd

Nasdaq · Unknown · Unknown · CIK 1876431 ·
Last close
$20.75
Market Cap
$319.95M
52W High
$23.63
52W Low
$14.00
ADV30
278,925
Next earnings
2026-08-10
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 35,954,000 23,283,000 -9,706,000 -23,104,000 175,302,000 56,017,000 54,280,000
Dec 2025 36,558,000 21,588,000 -13,136,000 -7,501,000 206,073,000 32,131,000 49,707,000
Sep 2025 23,555,000 14,024,000 -6,559,000 -7,408,000 196,507,000 13,264,000 35,305,000
Jun 2025 17,680,000 7,289,000 -9,869,000 -12,410,000 199,106,000 17,249,000 48,214,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-554,781,000
Inventory
$7,032,000
Receivables
$4,294,000
ST Investments
$31,192,000
EBIT TTM
$-38,230,000
Pretax Income TTM
$-38,464,000
Interest Exp TTM
$234,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$120,069,000
EBITDA
$-41,035,000
Free Cash Flow
$-84,654,752
Enterprise Value
$237,371,424
Total Cash
$115,381,000
Total Debt
$457,000
Shares Out
15,419,419
Trailing EPS
$-3.63
Book Value
$10.89
ROE
-40.8%
ROA
-13.5%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 92,390,000 -38,129,000 -37,709,000 206,073,000 49,707,000 -21,826,000
Dec 2024 15,936,000 -38,277,000 -46,304,000 213,575,000 42,229,000 -28,874,000
Dec 2023 6,155,000 -42,469,000 -62,724,000 254,171,000 44,013,000 -13,765,000
Dec 2022 13,164,000 -65,917,000 -190,454,000 312,131,231 68,668,371 14,515,000
Dec 2021

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.68

Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $15.00 · spot: $20.51 · call volume: 72 · put volume: 15
Expected Move to 2026-06-18: ±$1.70 (8.29%) — implied range $18.81$22.21 · ATM straddle on $20.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
BGT BLACKROCK FLOATING RATE INCOME TRUST $318.53M $10.68
MXF MEXICO FUND INC $321.57M $22.30
KF KOREA FUND INC $322.44M $77.54
RIV RIVERNORTH OPPORTUNITIES FUND, INC. $315.32M $11.52
RFMZ RiverNorth Flexible Municipal Income Fund II, Inc. $325.10M $13.35

News headlines (Yahoo Finance, 1h cache)

Sector Update: Healthcare Stocks Decline Late Afternoon
2026-06-10 19:33 · Yahoo
PRE Continues to Post Rapid Growth
2026-06-10 11:10 · Yahoo
Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion
2026-06-04 12:30 · Yahoo
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
2026-05-20 20:51 · Yahoo
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
2026-05-20 12:00 · Yahoo
Prenetics Global Ltd (PRE) Q1 2026 Earnings Call Highlights: Record Revenue Surge Amid ...
2026-05-14 23:03 · Yahoo
Prenetics Global Q1 Earnings Call Highlights
2026-05-14 19:05 · Yahoo
PRE Continues Astounding Growth, While Expanding Product Line
2026-05-14 12:41 · Yahoo
Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
2026-05-14 12:05 · Yahoo
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
2026-05-14 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.